(Q48840371)

16 February 2018

title

American Society of Clinical Oncology 2011 CNS tumors update. (English)

1 reference

16 February 2018

1 reference

Manmeet S Ahluwalia

1

1 reference

16 February 2018

publication date

1 October 2011

1 reference

16 February 2018

Expert Review of Anticancer Therapy

published in

1 reference

16 February 2018

volume

11

1 reference

16 February 2018

issue

10

1 reference

16 February 2018

page(s)

1495-1497

1 reference

16 February 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.151

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.151

Synergistic antiglioma activity of radiotherapy and enzastaurin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.151

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.151

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.151

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.151

Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.151

21 January 2018

Identifiers

DOI

10.1586/ERA.11.151

1 reference

16 February 2018

PubMed ID

21999122

1 reference

16 February 2018